Yinchiao

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of symptoms associated with the common cold, hay fever, or other upper respiratory allergies. The symptoms alleviated by this medication include minor aches and pains, headache, muscular aches, fever, sore throat, sneezing, itching of the nose or throat, runny nose, and itchy, watery eyes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are advised to take 6 tablets every 4 hours, with a maximum dosage of 36 tablets within a 24-hour period.

For children aged 6 to under 12 years, the recommended dosage is 3 tablets every 4 hours, not exceeding 18 tablets in a 24-hour timeframe.

In the case of children under 6 years of age, it is essential to consult a healthcare professional for appropriate dosing recommendations.

Contraindications

Use of this product is contraindicated for the management of pain for durations exceeding 10 days and for fever lasting more than 3 days. Prolonged use may lead to adverse effects and is not recommended.

The product may induce excitability, particularly in pediatric patients, and can cause drowsiness. The concomitant use of alcohol, sedatives, or tranquilizers may exacerbate drowsiness. Therefore, the consumption of alcoholic beverages is contraindicated during treatment.

Caution is advised when driving a motor vehicle or operating machinery due to the potential for impaired alertness.

Warnings and Precautions

It is imperative to keep this product out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center without delay. Prompt medical attention is essential for both adults and children, even if no signs or symptoms are initially apparent.

When utilizing this product, healthcare professionals should be aware of several general precautions. The product may induce excitability, particularly in children. Additionally, drowsiness may occur, and the sedative effects can be exacerbated by the consumption of alcohol, sedatives, or tranquilizers. Therefore, it is advised to avoid alcoholic beverages while using this product. Caution is also recommended when driving a motor vehicle or operating machinery due to the potential for impaired alertness.

In the case of an overdose, it is crucial to obtain emergency medical help or contact a Poison Control Center immediately.

Healthcare professionals should instruct patients to discontinue use and consult a physician if any of the following occur: pain or fever persists or worsens; new symptoms arise; redness or swelling is observed; or if a sore throat is severe, lasts longer than two days, or is accompanied by fever, headache, rash, nausea, or vomiting.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this medication. Serious adverse reactions may necessitate immediate medical attention. Patients are advised to stop use and consult a healthcare professional if any of the following occur: pain or fever persists or worsens, new symptoms arise, redness or swelling is present, or if a sore throat is severe, lasts for more than two days, or is accompanied or followed by fever, headache, rash, nausea, or vomiting.

Before initiating treatment, patients should seek medical advice if they have a history of glaucoma, breathing problems such as emphysema or chronic bronchitis, or difficulty in urination due to enlargement of the prostate gland. Additionally, it is recommended that patients consult a doctor or pharmacist prior to use if they are currently taking sedatives or tranquilizers, as these may interact with the medication.

Monitoring for these adverse reactions is essential to ensure patient safety and effective management of any potential complications.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Yinchiao (acetaminophen and chlorpheniramine maleate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may take 3 tablets every 4 hours, with a maximum of 18 tablets in a 24-hour period. For children under 6 years of age, consultation with a doctor is advised prior to use.

Caution is warranted as the medication may cause excitability, particularly in children. It is essential to keep the product out of reach of children. In the event of an overdose, immediate medical assistance should be sought, and contacting a Poison Control Center is recommended. Prompt medical attention is critical for both adults and children, even if no signs or symptoms are apparent.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Dosage adjustments may be necessary for patients with reduced renal function. Regular monitoring of renal function tests is recommended for patients with known kidney problems. A reduced dose should be considered in patients with a creatinine clearance of less than 30 mL/min. Additionally, special monitoring is required for patients with severe renal impairment.

Hepatic Impairment

Patients with hepatic impairment may experience altered metabolism of the drug, necessitating dosage adjustments to ensure safety and efficacy. It is essential to monitor liver function tests in this population to assess the degree of impairment and guide treatment decisions. Special precautions should be taken when administering the drug to patients with liver problems, as their compromised liver function may increase the risk of adverse effects or reduced therapeutic outcomes.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status.

2. Supportive Care: Initiate supportive measures as necessary, including airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable timeframe, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Consultation: Engage with a poison control center or toxicology expert for guidance on specific antidotes or additional management strategies tailored to the substance involved.

Monitoring should continue until the patient is stable and any potential complications are addressed. Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is critical for ongoing management and future reference.

Healthcare professionals are encouraged to familiarize themselves with local protocols and guidelines regarding overdose management to ensure prompt and effective intervention.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use.

In nonclinical studies, the substance has been associated with excitability, particularly in pediatric populations. Additionally, drowsiness has been observed, with the potential for increased effects when used in conjunction with alcohol, sedatives, or tranquilizers.

No relevant information regarding carcinogenicity, mutagenicity, or impairment of fertility has been extracted from the available data.

Postmarketing Experience

Serious adverse events associated with the use of this product have been reported voluntarily or through surveillance programs. Users are encouraged to report any such events to the appropriate authorities.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. In the event of an overdose, patients should seek medical help or contact a Poison Control Center immediately, as prompt medical attention is critical for both adults and children, even if no signs or symptoms are present.

Patients should be informed not to use this medication for pain for more than 10 days and not to use it for fever for more than 3 days. They should be instructed to stop use and consult a doctor if pain or fever persists or worsens, if new symptoms occur, or if there is any redness or swelling. Additionally, patients should be advised to stop use and seek medical advice if a sore throat is severe, lasts more than 2 days, or is accompanied or followed by fever, headache, rash, nausea, or vomiting.

It is important to inform patients that this product may cause excitability, particularly in children, and may also lead to drowsiness. Patients should be cautioned that the effects of drowsiness may be increased when combined with alcohol, sedatives, or tranquilizers. Therefore, they should avoid alcoholic beverages and use caution when driving a motor vehicle or operating machinery.

Patients should be encouraged to consult a doctor before using this medication if they have glaucoma, breathing problems such as emphysema or chronic bronchitis, or difficulty urinating due to an enlarged prostate gland. Furthermore, patients should be advised to speak with a doctor or pharmacist before use if they are currently taking sedatives or tranquilizers.

Storage and Handling

The product is supplied in a manner that ensures optimal preservation of its integrity. It is essential to protect the product from light and excessive heat to maintain its efficacy. The container must be kept tightly closed to prevent contamination and degradation. Additionally, it should be stored in a dry place to avoid moisture-related issues. Proper adherence to these storage conditions is crucial for the product's stability and effectiveness.

Additional Clinical Information

The product is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is essential to keep the product out of reach of children. In the event of an overdose, patients should seek medical assistance or contact a Poison Control Center immediately, as prompt medical attention is crucial for both adults and children, even if no symptoms are apparent.

Additionally, patients and healthcare providers are encouraged to report any serious adverse events associated with the use of this product.

Drug Information (PDF)

This file contains official product information for Yinchiao, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)